salicylaldehyde isonicotinoyl hydrazone has been researched along with Cardiac Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamcová, M; Gersl, V; Guncová, I; Kaiserová, H; Mazurová, Y; Palicka, V; Ponka, P; Popelová, O; Potácová, A; Simůnek, T; Sterba, M | 1 |
1 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and Cardiac Diseases
| Article | Year |
|---|---|
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
Topics: Aldehydes; Animals; Cells, Cultured; Daunorubicin; Heart Diseases; Heart Ventricles; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Myocytes, Cardiac; Rabbits; Rats; Troponin T | 2007 |